Stockscreener 앱 받기
330.59
0.72%
-2.629
전일 마감가:
$333.22
열려 있는:
$330.22
하루 거래량:
141.86K
Relative Volume:
0.24
시가총액:
$23.78B
수익:
$2.88B
순이익/손실:
$499.60M
주가수익비율:
44.61
EPS:
7.41
순현금흐름:
$321.60M
1주 성능:
+0.38%
1개월 성능:
+1.58%
6개월 성능:
+0.43%
1년 성능:
-6.05%
1일 변동 폭
$327.05
$330.96
1주일 범위
$327.05
$334.32
52주 변동 폭
$265.00
$413.70
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
330.63 | 23.78B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
528.11 | 185.90B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
226.99 | 65.06B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.98 | 41.72B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
230.24 | 33.65B | 4.81B | 1.11B | 1.35B | 7.55 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference - The Eastern Progress Online
West Pharmaceutical Services Inc. stock rises Tuesday, still underperforms market - MarketWatch
Dudley & Shanley Inc. Has $24.35 Million Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Is It Too Late To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)? - Yahoo Finance
West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Not Quite Adding Up - Simply Wall St
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now - MSN
How Is West Pharmaceutical Services' Stock Performance Compared to Other Medical Devices Stocks? - MSN
Top 10 Companies in Pre Filled Syringe [2025] - Verified Market Reports
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Janet Haugen Joins West Pharmaceutical Services Board of Directors - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) Stake Lifted by Sanctuary Advisors LLC - MarketBeat
Connected Drug Delivery Devices Market is Dazzling Worldwide - openPR
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Orion Portfolio Solutions LLC Sells 4,029 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by XTX Topco Ltd - MarketBeat
West Pharmaceutical Services Inc. stock rises Monday, still underperforms market - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
West Pharmaceutical announces new share repurchase program By Investing.com - Investing.com Australia
Bank of America Increases West Pharmaceutical Services (NYSE:WST) Price Target to $355.00 - MarketBeat
Wilmington Savings Fund Society FSB Buys New Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services authorizes share buyback program - TradingPedia
West Pharmaceutical initiated with a Peer Perform at Wolfe Research - Yahoo Finance
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Franklin Resources Inc. - MarketBeat
Virtu Financial LLC Acquires New Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Wolfe Research starts West Pharmaceutical stock with Peerperform rating - Investing.com
West Pharmaceutical announces new share repurchase program - Investing.com
West Pharmaceutical Services (WST) Announces New Share Repurchas - GuruFocus.com
Wolfe Research Initiates Coverage of West Pharmaceutical Services (WST) with Peer Perform Recommendation - Nasdaq
West Elects New Director to the Board - Kilgore News Herald
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services to Buy Back Up To 550,000 Shares - MarketWatch
West Pharmaceutical Services (NYSE:WST) Coverage Initiated by Analysts at Wolfe Research - MarketBeat
West Pharmaceutical upgraded to Buy from Neutral at UBS - Yahoo Finance
Geode Capital Management LLC Buys 12,850 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Quantinno Capital Management LP Grows Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
How ready are you? Annex 1 and the impact of primary packaging - European Pharmaceutical Manufacturer
West Pharmaceutical Services (NYSE:WST) Upgraded by UBS Group to Buy Rating - MarketBeat
Public Employees Retirement System of Ohio Cuts Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Stifel Financial Corp Trims Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services expands board with new director By Investing.com - Investing.com South Africa
West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards - The Eastern Progress Online
West Pharmaceutical expanding Kinston operations - Kinston Free Press
West Pharmaceutical Expands Board with New Director - TipRanks
West Elects Janet Haugen Director to the Board - citybiz
West Pharmaceutical Services expands board with new director - Investing.com
National Bank of Canada FI Raises Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Should You Sell Your Holdings in West Pharmaceutical Services (WST)? - Insider Monkey
IVD Contract Manufacturing Market to Surpass Valuation of USD 39.74 Billion by 2031 | SkyQuest Technology - Benzinga
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Groupama Asset Managment - MarketBeat
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
West Pharmaceutical Services Inc 주식 (WST) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Witherspoon Charles | VP & Treasurer |
Oct 29 '24 |
Sale |
310.40 |
703 |
218,211 |
1,253 |
| Abraham Silji | SVP, Chief Technology Officer |
Oct 29 '24 |
Option Exercise |
0.00 |
458 |
0 |
3,318 |
| Witherspoon Charles | VP & Treasurer |
Aug 19 '24 |
Option Exercise |
102.51 |
529 |
54,228 |
2,507 |
| Witherspoon Charles | VP & Treasurer |
Aug 19 '24 |
Sale |
300.00 |
1,029 |
308,700 |
1,478 |
| Hofmann Thomas W | Director |
May 10 '24 |
Sale |
365.92 |
617 |
225,773 |
43,565 |
| Green Eric Mark | President, CEO and Board Chair |
Aug 06 '24 |
Option Exercise |
59.64 |
36,732 |
2,190,696 |
192,640 |
| Green Eric Mark | President, CEO and Board Chair |
Aug 06 '24 |
Sale |
304.71 |
30,732 |
9,364,409 |
161,898 |
0.56%
자본화:
|
볼륨(24시간):